myDExTailored myDEx Online HIV Prevention Intervention for Young Men
myDEx
+ NTHP
Blood-Borne Infections+11
+ Urogenital Diseases
+ Genital Diseases
Prevention Study
Summary
Study start date: November 1, 2016
Actual date on which the first participant was enrolled.There's been an increase in new HIV cases among young men who have sex with men (YMSM), aged 18-24. To address this, a tailored, web-based intervention called 'myDEx' is being developed. This program aims to deliver HIV prevention messages based on a single YMSM's relationship expectations and partner-seeking behaviors. To ensure the intervention is appealing and appropriate, a youth advisory board (YAB) provides insight and feedback during its development. The main goal is to align YMSM's relationship experiences and desires with HIV prevention strategies. In this study, participants will engage with either the tailored myDEx intervention or a non-tailored HIV/AIDS prevention (NTHP) comparison intervention. Feedback on the intervention's design and acceptability will be collected from 16 YMSM. After any recommended changes are made, a small pilot randomized controlled trial (RCT) will be launched. This trial will compare myDEx with NTHP to assess intervention feasibility and acceptability, and gather preliminary behavioral data. Assessments will be conducted at 30, 60, and 90 days follow-up. The study will evaluate changes in HIV testing behavior and the number of risky sexual partnerships from the beginning to the end of the study.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.180 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Male
Biological sex of participants that are eligible to enroll.From 18 to 24 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location